Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Mizoribine for lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Mizoribine (mizoribine)

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Lupus Nephritis | Phase 3 | Status: COMPLETED